LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,889 | +20.9% | 5,209 | +24.2% | 0.00% | 0.0% |
| Q2 2023 | $289,443 | +33.6% | 4,193 | -6.7% | 0.00% | 0.0% |
| Q1 2023 | $216,604 | -19.0% | 4,492 | -16.2% | 0.00% | 0.0% |
| Q4 2022 | $267,471 | +17.3% | 5,358 | +29.1% | 0.00% | 0.0% |
| Q2 2022 | $228,000 | +12.9% | 4,149 | -25.4% | 0.00% | – |
| Q1 2022 | $202,000 | -30.8% | 5,565 | -11.2% | 0.00% | -100.0% |
| Q4 2021 | $292,000 | -15.4% | 6,267 | -8.2% | 0.00% | 0.0% |
| Q3 2021 | $345,000 | – | 6,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |